Wedbush Securities Inc Tekla Life Sciences Investors Transaction History

Wedbush Securities Inc

  • $2.7 Billion
  • Q3 2024

A detailed history of Wedbush Securities Inc transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Wedbush Securities Inc holds 16,273 shares of HQL stock, worth $228,310. This represents 0.01% of its overall portfolio holdings.

Number of Shares
16,273
Previous 16,673 2.4%
Holding current value
$228,310
Previous $236,000 3.81%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$14.26 - $15.78 $5,704 - $6,312
-400 Reduced 2.4%
16,273 $245,000
Q2 2024

Aug 06, 2024
BUY
$12.79 - $14.27 $16,128 - $17,994
1,261 Added 8.18%
16,673 $236,000
Q1 2024

May 14, 2024
SELL
$13.38 - $14.33 $62,886 - $67,351
-4,700 Reduced 23.37%
15,412 $210,000
Q4 2023

Feb 12, 2024
SELL
$11.35 - $13.6 $29,782 - $35,686
-2,624 Reduced 11.54%
20,112 $271,000
Q3 2023

Nov 14, 2023
BUY
$12.38 - $13.69 $37,140 - $41,070
3,000 Added 15.2%
22,736 $284,000
Q2 2023

Aug 14, 2023
BUY
$13.13 - $14.17 $22,636 - $24,429
1,724 Added 9.57%
19,736 $267,000
Q1 2023

May 09, 2023
BUY
$13.37 - $14.94 $16,712 - $18,675
1,250 Added 7.46%
18,012 $251,000
Q4 2022

Jan 31, 2023
BUY
$13.55 - $15.23 $33,197 - $37,313
2,450 Added 17.12%
16,762 $238,000
Q3 2022

Oct 18, 2022
BUY
$13.39 - $16.31 $4,258 - $5,186
318 Added 2.27%
14,312 $195,000
Q2 2022

Jul 21, 2022
BUY
$13.11 - $17.02 $10,802 - $14,024
824 Added 6.26%
13,994 $199,000
Q1 2022

Apr 19, 2022
BUY
$15.35 - $19.29 $45,666 - $57,387
2,975 Added 29.18%
13,170 $217,000
Q4 2021

Jan 13, 2022
BUY
$18.5 - $21.59 $2,016 - $2,353
109 Added 1.08%
10,195 $196,000
Q3 2021

Oct 08, 2021
SELL
$20.27 - $22.67 $344 - $385
-17 Reduced 0.17%
10,086 $209,000
Q2 2021

Jul 27, 2021
BUY
$19.14 - $21.44 $193,371 - $216,608
10,103 New
10,103 $216,000
Q2 2019

Aug 01, 2019
SELL
$15.54 - $17.47 $169,588 - $190,650
-10,913 Closed
0 $0
Q1 2019

Apr 17, 2019
BUY
$15.5 - $17.9 $169,151 - $195,342
10,913 New
10,913 $187,000
Q4 2018

Jan 31, 2019
SELL
$13.99 - $20.35 $163,780 - $238,237
-11,707 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$18.89 - $20.49 $221,145 - $239,876
11,707 New
11,707 $239,000

Others Institutions Holding HQL

# of Institutions
77
Shares Held
9.86M
Call Options Held
0
Put Options Held
0
View Full List

About TEKLA LIFE SCIENCES INVESTORS

HQL Quotes by TradingView
  • Ticker HQL
  • Exchange NYSE
  • Sector Financial Services
  • Industry Asset Management
  • Description
  • Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...
More about HQL
Track This Portfolio

Track Wedbush Securities Inc Portfolio

Follow Wedbush Securities Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedbush Securities Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email